eosine yellowish-(ys) has been researched along with Idiopathic Inflammatory Myopathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aguilar-Vazquez, A; Armendariz-Borunda, J; Chavarria-Avila, E; Duran-Barragan, S; Godínez-Rubí, M; Gómez-Limón, L; Gomez-Rios, CA; Llamas-Garcia, A; Lozano-Torres, Y; Lundberg, I; Martin-Marquez, BT; Martinez-Garcia, EA; Medina-Preciado, JD; Palacios-Zárate, BL; Pizano-Martinez, O; Rodríguez-Baeza, M; Salazar-Paramo, M; Sandoval-Rodriguez, A; Toriz-González, G; Vazquez-Del Mercado, M; Villanueva-Pérez, A | 1 |
1 other study(ies) available for eosine yellowish-(ys) and Idiopathic Inflammatory Myopathies
Article | Year |
---|---|
Impaired muscle strength is associated with ultrastructure damage in myositis.
Topics: Autoantibodies; Eosine Yellowish-(YS); Hematoxylin; Humans; Interleukin-10; Interleukin-17; Interleukin-18; Interleukin-23; Interleukin-33; Interleukin-6; Muscle Strength; Myositis; Tumor Necrosis Factor-alpha | 2022 |